Medeon Biodesign (ROCO:6499) 3-Year Revenue Growth Rate : -13.20% (As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Medeon Biodesign 3-Year Revenue Growth Rate?

Medeon Biodesign's Revenue per Share for the three months ended in Jun. 2024 was NT$0.69.

During the past 12 months, Medeon Biodesign's average Revenue per Share Growth Rate was 42.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was -13.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was -16.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 12 years, the highest 3-Year average Revenue per Share Growth Rate of Medeon Biodesign was 130.00% per year. The lowest was -55.40% per year. And the median was -13.50% per year.

Competitive Comparison of Medeon Biodesign's 3-Year Revenue Growth Rate

For the Medical Instruments & Supplies subindustry, Medeon Biodesign's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medeon Biodesign's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medeon Biodesign's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Medeon Biodesign's 3-Year Revenue Growth Rate falls into.

Medeon Biodesign 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Medeon Biodesign (ROCO:6499) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Medeon Biodesign 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Medeon Biodesign's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Medeon Biodesign Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medeon Biodesign Inc (ROCO:6499) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 116, HouGang Street, 7th Floor, Shilin District, Taipei, TWN, 11170

Website

http://www.medeonbio.com

Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.

Medeon Biodesign Headlines

No Headlines